Financial Ratios

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE5595.25-66.15 (-1.17 %)
PREV CLOSE ( ) 5661.40
OPEN PRICE ( ) 5530.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1384
TODAY'S LOW / HIGH ( )5530.00 5824.00
52 WK LOW / HIGH ( )3742.9 6452.85
NSE5584.50-79.5 (-1.4 %)
PREV CLOSE( ) 5664.00
OPEN PRICE ( ) 5663.00
BID PRICE (QTY) 5584.50 (28)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 57233
TODAY'S LOW / HIGH( ) 5540.00 5825.00
52 WK LOW / HIGH ( )3701 6451.15
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)120.51136.38133.89108.77111.29
   CEPS(Rs)134.12159.44159.03132.68133.85
   DPS(Rs)35.0070.0030.0035.00330.00
   Book NAV/Share(Rs)785.91701.05626.10523.07742.18
   Tax Rate(%)26.1024.2820.7425.5920.76
Margin Ratios
   Core EBITDA Margin(%)27.4331.6030.7931.8226.62
   EBIT Margin(%)32.8832.7128.8630.5630.37
   Pre Tax Margin(%)32.2132.1828.4629.8729.86
   PAT Margin (%)23.8124.3722.5622.2323.66
   Cash Profit Margin (%)26.4928.4926.7927.1228.46
Performance Ratios
   ROA(%)13.6516.0917.2413.0012.20
   ROE(%)16.2120.5523.3017.1915.89
   ROCE(%)22.3727.5629.7823.6220.38
   Asset Turnover(x)0.570.660.760.580.52
   Sales/Fixed Asset(x)1.711.902.071.751.81
   Working Capital/Sales(x)1.061.391.802.041.01
Efficiency Ratios
   Fixed Capital/Sales(x)0.580.530.480.570.55
   Receivable days26.7420.9816.8922.8929.15
   Inventory Days67.0961.7759.4170.5769.32
   Payable days95.85109.35114.15176.59212.28
Valuation Parameters
   PER(x)34.8025.4032.5041.5736.17
   PCE(x)31.2721.7327.3634.0830.07
   Price/Book(x)5.344.946.958.645.42
   Yield(%)0.832.020.690.778.20
   EV/Net Sales(x)7.825.777.008.747.53
   EV/Core EBITDA(x)21.0115.3720.3324.6721.40
   EV/EBIT(x)22.5116.7123.3128.6124.78
   EV/CE(x)4.764.364.746.024.77
   M Cap / Sales8.756.547.629.248.56
Growth Ratio
   Net Sales Growth(%)-9.55-7.1316.644.043.37
   Core EBITDA Growth(%)-10.351.2713.244.863.24
   EBIT Growth(%)-9.076.8814.544.68-1.23
   PAT Growth(%)-11.641.8623.10-2.2618.66
   EPS Growth(%)-11.641.8623.10-2.2618.66
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)5.013.792.772.423.45
   Quick Ratio(x)4.223.162.241.872.96
   Interest Cover(x)49.3562.1373.2344.4559.36
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.